doxorubicin derivative (Pro-Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin derivative (Pro-Pharmaceuticals)
Drug Alias Namedoxorubicin derivative (UCLT) (Pro-Pharmaceuticals)galactomycin IIGalactomycingalactomycin I
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitorsDNA intercalators
TargetsTopoisomerase IIDNAVirus DNA polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalectin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalectin Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A